PFA Pension Forsikringsaktieselskab Takes Position in McKesson Corporation $MCK

Key Points

• PFA Pension Forsikringsaktieselskab bought a new stake of 84,216 McKesson shares valued at about $69.68 million, representing roughly 0.07% ownership.
• McKesson beat quarterly expectations with EPS of $9.34 on $106.16 billion revenue, and set FY2026 guidance of 38.80–39.20 EPS (analysts forecast ~39.02 EPS).
• Analyst sentiment is positive: 14 Buys and 3 Holds lead to a consensus Moderate Buy rating and an average price target of $972.27, with some targets up to $1,050.

PFA Pension Forsikringsaktieselskab purchased a new stake in McKesson Corporation (NYSE:MCK - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 84,216 shares of the company's stock, valued at approximately $69,675,000. PFA Pension Forsikringsaktieselskab owned approximately 0.07% of McKesson as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC increased its position in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP acquired a new position in shares of McKesson during the first quarter worth $233,000. Sivia Capital Partners LLC increased its position in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock worth $502,000 after purchasing an additional 300 shares in the last quarter. Treasurer of the State of North Carolina increased its position in shares of McKesson by 0.9% during the second quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company's stock worth $42,958,000 after purchasing an additional 508 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new position in shares of McKesson during the second quarter worth $166,000. 85.07% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

MCK has been the topic of a number of recent analyst reports. Wells Fargo & Company upped their price target on McKesson from $914.00 to $925.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 5th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 18th. Robert W. Baird set a $968.00 price target on McKesson in a research report on Wednesday, January 14th. TD Cowen upped their price target on McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th. Finally, UBS Group reduced their price target on McKesson from $1,012.00 to $1,000.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, McKesson has an average rating of "Moderate Buy" and an average price target of $972.27.

Insider Activity at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares of the company's stock, valued at $3,214,530. The trade was a 45.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Maria Martinez sold 349 shares of the business's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the transaction, the director owned 301 shares of the company's stock, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 3,592 shares of company stock valued at $3,518,555 over the last three months. 0.08% of the stock is owned by corporate insiders.

McKesson Price Performance

Shares of MCK opened at $814.69 on Friday. The firm has a market capitalization of $99.79 billion, a PE ratio of 23.43, a price-to-earnings-growth ratio of 1.18 and a beta of 0.35. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The company's fifty day moving average price is $894.86 and its 200-day moving average price is $859.80.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business's quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the company earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts anticipate that McKesson Corporation will post 39.02 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson's payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.